What happens when the NHS becomes the testbed?
A new health innovation sandbox in Manchester will put emerging technologies into real NHS settings. The bigger question is what…
A new health innovation sandbox in Manchester will put emerging technologies into real NHS settings. The bigger question is what happens when innovation meets reality.
Manchester University NHS Foundation Trust and the Medicines and Healthcare products Regulatory Agency are doing something interesting.
They’re creating a place where promising health technologies can be tested with actual patients and clinicians – before anyone tries to scale them across the NHS.
The new Manchester Sandbox will bring regulators, healthcare teams and innovators together earlier, testing technology under controlled conditions and building evidence around whether it is safe, effective and genuinely useful in practice.
That distinction matters.
A technology can work brilliantly in development and still struggle when it meets a real hospital. Different patients. Existing systems. Busy clinical teams. Regulation. Safety requirements. The everyday complexity that doesn’t necessarily show up in a lab.
A sandbox sounds like somewhere to play. This is closer to a controlled proving ground.
The first technologies are expected to include AI-enabled medical devices, including tools designed to identify patients at greater risk of complications from long-term conditions so clinicians can intervene earlier.
The ambition goes beyond Manchester. Evidence from the programme will be shared more widely, with the potential to inform how new technologies are evaluated and introduced elsewhere in the NHS. The MHRA also plans to invite medical-device developers to put themselves forward for future phases.
Patients should benefit from innovation as quickly as possible, but they should never have to choose between access and safety.
That is the tension sitting underneath the whole experiment.
We talk a lot about accelerating innovation. But in healthcare, faster cannot simply mean removing obstacles. Some of those obstacles exist for good reason.
The more interesting challenge is how you bring testing, regulation and implementation closer together – so problems surface earlier, evidence gets stronger and technologies that genuinely work have a clearer route into everyday use.
If Manchester gets that right, the valuable output may not only be the individual technologies it tests. It could be a better model for how the NHS decides what deserves to scale.
And that question extends well beyond healthcare.
How do you take an idea that works in theory and turn it into a system people can actually trust?
That’s one of the questions we’ll be getting into at the Future Forum Flagship in King’s Cross this October – bringing together the people building new technology with those responsible for making it work in the real world.